Filing Details
- Accession Number:
- 0000899243-22-014963
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-18 16:15:14
- Reporting Period:
- 2022-04-14
- Accepted Time:
- 2022-04-18 16:15:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840904 | Atai Life Sciences N.v. | ATAI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1845711 | Ltd. Group Investment Apeiron | 66 &Amp; 67, Beatrice, Amery Street Sliema O1 SLM1707 | No | No | Yes | No | |
| 1845872 | Christian Angermayer | 66 &Amp; 67, Beatrice, Amery Street Sliema O1 SLM1707 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-04-14 | 4,967 | $5.19 | 1,358,883 | No | 4 | P | Indirect | By Apeiron Presight Capital Fund II, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Apeiron Presight Capital Fund II, L.P. |
Footnotes
- The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $5.13 to $5.20 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
